estrogen receptor modulators (Weizmann/Tel Aviv Sourasky Medical Center)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameestrogen receptor modulators (Weizmann/Tel Aviv Sourasky Medical Center)
Drug Alias NamecD-tBocestrogen receptor modulators (Weizmann)carboxy-daidzein-tBoc (Weizmann)phytoestrogen selective estrogen receptor modulator (Weizmann/BioLineRx)isoflavone derivatives (Weizmann) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha modulators
TargetsEstrogen receptor alpha
Therapy Area/IndicationsOsteoporosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdYeda Research and Development Co LtdWeizmann Institute Of Science +[4] 
Active IndicationsN/A
Inactive IndicationsOsteoporosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A